RISPERDAL M-TAB

US serial number:85006963
Application filling date:Apr. 06, 2010
Register:Principal
Mark type:Trademark
Status:Registered. The registration date is used to determine when post-registration maintenance documents are due.
Status date:Nov. 22, 2011
Publication date:Sep. 06, 2011
Standard character claim:Yes. The mark consists of standard characters without claim to any particular font style, size, or color.
Mark drawing type:4 - STANDARD CHARACTER MARK
Goods and services:For: Pharmaceuticals, namely, antipsychotics International Class(es): 005- Primary Class U.S Class(es): 006,018,044,046,051,052 Class Status: ACTIVE Basis: 1(a) First Use: Sep. 04, 2003 Use in Commerce: Sep. 04, 2003
Services:Pharmaceuticals namely antipsychotics
Current owner owner name:JOHNSON & JOHNSON
Current owner owner address:One Johnson & Johnson Plaza New Brunswick, NEW JERSEY UNITED STATES 089337001
Current owner legal entity type:CORPORATION
Current owner state or country:NEW JERSEY
Attorney name:Matthew Pater
Attorney email:tmus@its.jnj.com
Attorney email authorized:Yes
Correspondent name address:Matthew Pater One Johnson & Johnson Plaza New Brunswick, NEW JERSEY UNITED STATES 08933
Correspondent phone:732-524-2826
Correspondent email:tmus@its.jnj.com kmanchen@its.jnj.com
Correspondent fax:732-524-6341
Correspondent email authorized RISPERDAL M-TAB:Yes

Reviews

Required fields are marked *